Downloadable Slidesets

Share

Program Content

Activities

  • HR+/HER2- EBC Tx Benefit
    Prognostic and Predictive Measures of Therapeutic Benefit in Early Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

  • HR+/HER2- EBC Neoadj Tx
    Neoadjuvant Therapy Considerations With CDK4/6 Inhibitors in HR+/HER2- EBC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

  • Adj Tx for HR+/HER2- EBC
    Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 16, 2021

  • <i>EP</i>: HR+/HER2- EBC
    ExpressPoints:
    Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 18, 2021

    Expires: June 17, 2022

Faculty

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Lilly